(Q33388518)

26 July 2017

title

Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes (English)

1 reference

26 July 2017

3

Michael Kundi

1 reference

26 July 2017

2

Ulrich Germing

1 reference

26 July 2017

Sabine Blum

5

1 reference

ORCID Public Data File 2021

author name string

Friedrich Wimazal

1

1 reference

26 July 2017

Thomas Noesslinger

4

1 reference

26 July 2017

Philipp Geissler

6

1 reference

26 July 2017

Christian Baumgartner

7

1 reference

26 July 2017

Michael Pfeilstoecker

8

1 reference

26 July 2017

Peter Valent

9

1 reference

26 July 2017

Wolfgang R Sperr

10

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

26 July 2017

1 reference

26 July 2017

volume

116

1 reference

26 July 2017

issue

10

1 reference

26 July 2017

page(s)

2372-2381

1 reference

Proposals for the classification of the myelodysplastic syndromes

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

Myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Epidemiology of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

The incidence and impact of thrombocytopenia in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Prognostic implications of basophil differentiation in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Characteristics of accelerated disease in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Prognostic features at diagnosis of chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Eosinophilia: secondary, clonal and idiopathic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Polychondritis Terminating in Eosinophilic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25036

7 January 2021

Identifiers

DOI

10.1002/CNCR.25036

1 reference

26 July 2017

1 reference